{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,15]],"date-time":"2026-07-15T16:57:50Z","timestamp":1784134670274,"version":"3.55.0"},"reference-count":67,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,1,7]],"date-time":"2022-01-07T00:00:00Z","timestamp":1641513600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,1,7]],"date-time":"2022-01-07T00:00:00Z","timestamp":1641513600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Vet Res"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec><jats:title>Background<\/jats:title><jats:p>Cardiac wall stress and high oxidative stress are often found in cases of myxomatous mitral valve degenerative (MMVD) disease and can lead to myocardial injuries and cardiac dysfunction. Melatonin, an antioxidant, has been shown to exert cardioprotection in laboratory animal models. However, its effect on metabolic parameters and left ventricular (LV) adaptation in MMVD dogs has rarely been investigated. This clinical trial hypothesized that a melatonin supplement for 4 weeks would improve metabolic parameters, LV structure (diameters and wall thickness), and LV function in MMVD dogs. Blood profiles, echocardiograms, and oxidative stress levels were obtained from 18 dogs with MMVD stage B2 and C at baseline and after prescribed Melatonin (2\u2009mg\/kg) for 4 weeks. Eleven dogs with MMVD stage B2 and C, which received a placebo, were evaluated as a control group.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>In this clinical trial, the baseline plasma malondialdehyde (MDA) was no different between the treatment and placebo groups. The post-treatment plasma MDA levels (4.50\u2009\u00b1\u20090.63\u2009mg\/mL) in the treatment group was significantly decreased after 4 weeks of melatonin supplementation compared to pre-treatment levels (7.51\u2009\u00b1\u20091.11\u2009mg\/mL) (<jats:italic>P<\/jats:italic>\u2009=\u20090.038). However, blood profiles and LV structure and function investigated using echocardiography were found not to different between pre-and post-treatment in each group. No adverse effects were observed following melatonin supplementation.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusions<\/jats:title><jats:p>This clinical trial demonstrated that a melatonin supplement for 4 weeks can attenuate oxidative stress levels in MMVD dogs, especially in MMVD stage C, but does not result in LV structural changes or LV function in MMVD dogs of either stage B2 or stage C.<\/jats:p><\/jats:sec>","DOI":"10.1186\/s12917-021-03125-z","type":"journal-article","created":{"date-parts":[[2022,1,7]],"date-time":"2022-01-07T11:03:35Z","timestamp":1641553415000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Short-term melatonin supplementation decreases oxidative stress but does not affect left ventricular structure and function in myxomatous mitral valve degenerative dogs"],"prefix":"10.1186","volume":"18","author":[{"given":"Wanpitak","family":"Pongkan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chanon","family":"Piamsiri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sirada","family":"Dechvongya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Verasak","family":"Punyapornwitthaya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chavalit","family":"Boonyapakorn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,1,7]]},"reference":[{"issue":"1","key":"3125_CR1","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1016\/j.jvc.2012.01.006","volume":"14","author":"HG Parker","year":"2012","unstructured":"Parker HG, Kilroy-Glynn P. Myxomatous mitral valve disease in dogs: does size matter? J Vet Cardiol. 2012;14(1):19\u201329.","journal-title":"J Vet Cardiol"},{"issue":"2","key":"3125_CR2","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1007\/s10741-012-9365-4","volume":"19","author":"AM Segura","year":"2014","unstructured":"Segura AM, Frazier OH, Buja LM. Fibrosis and heart failure. Heart Fail Rev. 2014;19(2):173\u201385.","journal-title":"Heart Fail Rev"},{"issue":"6","key":"3125_CR3","doi-asserted-by":"publisher","first-page":"709","DOI":"10.1161\/CIRCRESAHA.113.300376","volume":"113","author":"T Doenst","year":"2013","unstructured":"Doenst T, Nguyen TD, Abel ED. Cardiac metabolism in heart failure: implications beyond ATP production. Circ Res. 2013;113(6):709\u201324.","journal-title":"Circ Res"},{"key":"3125_CR4","doi-asserted-by":"crossref","unstructured":"Ware WA. Cardiovascular disease in small animal medicine. London: Manson Pub.\/The Veterinary Press; 2011.","DOI":"10.1201\/b15177"},{"key":"3125_CR5","doi-asserted-by":"publisher","unstructured":"Melenovsky V. Cardiac adaptation to Volume Overload. Cardiac Adaptations Molecular Mechanisms. New York: Springer Science+Business Media; 2013. p. 167\u201399. https:\/\/doi.org\/10.1007\/978-1-4614-5203-4_9.","DOI":"10.1007\/978-1-4614-5203-4_9"},{"issue":"1","key":"3125_CR6","doi-asserted-by":"publisher","first-page":"176","DOI":"10.1186\/s12917-021-02878-x","volume":"17","author":"A Nemec Svete","year":"2021","unstructured":"Nemec Svete A, Verk B, Cebulj-Kadunc N, Salobir J, Rezar V, Domanjko PA. Inflammation and its association with oxidative stress in dogs with heart failure. BMC Vet Res. 2021;17(1):176.","journal-title":"BMC Vet Res"},{"issue":"3","key":"3125_CR7","doi-asserted-by":"publisher","first-page":"258","DOI":"10.1111\/jvp.12746","volume":"42","author":"P Thassakorn","year":"2019","unstructured":"Thassakorn P, Patchanee P, Pongkan W, Chattipakorn N, Boonyapakorn C. Effect of atorvastatin on oxidative stress and inflammation markers in myxomatous mitral valve disease in dogs: a comparison of subclinical and clinical stages. J Vet Pharmacol Ther. 2019;42(3):258\u201367.","journal-title":"J Vet Pharmacol Ther"},{"issue":"4","key":"3125_CR8","doi-asserted-by":"crossref","first-page":"673","DOI":"10.24425\/124305","volume":"21","author":"K Mangkhang","year":"2018","unstructured":"Mangkhang K, Punyapornwithaya V, Tankaew P, Pongkan W, Chattipakorn N, Boonyapakorn C. Plasma humanin as a prognostic biomarker for canine myxomatous mitral valve disease: a comparison with plasma NT-roBNP. Pol J Vet Sci. 2018;21(4):673\u201380.","journal-title":"Pol J Vet Sci"},{"key":"3125_CR9","doi-asserted-by":"publisher","first-page":"483","DOI":"10.1016\/j.redox.2013.07.006","volume":"1","author":"E Ho","year":"2013","unstructured":"Ho E, Karimi Galougahi K, Liu CC, Bhindi R, Figtree GA. Biological markers of oxidative stress: applications to cardiovascular research and practice. Redox Biol. 2013;1:483\u201391.","journal-title":"Redox Biol"},{"issue":"3","key":"3125_CR10","doi-asserted-by":"publisher","first-page":"393","DOI":"10.13075\/mp.5893.00137","volume":"66","author":"M Czerska","year":"2015","unstructured":"Czerska M, Mikolajewska K, Zielinski M, Gromadzinska J, Wasowicz W. Today's oxidative stress markers. Med Pr. 2015;66(3):393\u2013405.","journal-title":"Med Pr"},{"key":"3125_CR11","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1016\/j.rvsc.2018.09.007","volume":"121","author":"CP Rubio","year":"2018","unstructured":"Rubio CP, Tvarijonaviciute A, Caldin M, Hernandez-Ruiz J, Ceron JJ, Martinez-Subiela S, et al. Stability of biomarkers of oxidative stress in canine serum. Res Vet Sci. 2018;121:85\u201393.","journal-title":"Res Vet Sci"},{"issue":"2","key":"3125_CR12","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1016\/0003-2697(66)90167-9","volume":"16","author":"ZA Placer","year":"1966","unstructured":"Placer ZA, Cushman LL, Johnson BC. Estimation of product of lipid peroxidation (malonyl dialdehyde) in biochemical systems. Anal Biochem. 1966;16(2):359\u201364.","journal-title":"Anal Biochem"},{"issue":"4","key":"3125_CR13","doi-asserted-by":"publisher","first-page":"472","DOI":"10.20945\/2359-3997000000066","volume":"62","author":"FGD Amaral","year":"2018","unstructured":"Amaral FGD, Cipolla-Neto J. A brief review about melatonin, a pineal hormone. Arch Endocrinol Metab. 2018;62(4):472\u20139.","journal-title":"Arch Endocrinol Metab"},{"issue":"16","key":"3125_CR14","doi-asserted-by":"publisher","first-page":"3190","DOI":"10.1111\/bph.14116","volume":"175","author":"N Zisapel","year":"2018","unstructured":"Zisapel N. New perspectives on the role of melatonin in human sleep, circadian rhythms and their regulation. Br J Pharmacol. 2018;175(16):3190\u20139.","journal-title":"Br J Pharmacol"},{"issue":"5","key":"3125_CR15","first-page":"245","volume":"48","author":"G Escames","year":"2009","unstructured":"Escames G, Acuna-Castroviejo D. Melatonin, synthetic analogs, and the sleep\/wake rhythm. Rev Neurol. 2009;48(5):245\u201354.","journal-title":"Rev Neurol"},{"issue":"5","key":"3125_CR16","first-page":"325","volume":"29","author":"RJ Reiter","year":"2014","unstructured":"Reiter RJ, Tan DX, Galano A. Melatonin: exceeding expectations. Physiology (Bethesda). 2014;29(5):325\u201333.","journal-title":"Physiology (Bethesda)"},{"issue":"4","key":"3125_CR17","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1111\/jpi.12175","volume":"57","author":"Y Yang","year":"2014","unstructured":"Yang Y, Sun Y, Yi W, Li Y, Fan C, Xin Z, et al. A review of melatonin as a suitable antioxidant against myocardial ischemia-reperfusion injury and clinical heart diseases. J Pineal Res. 2014;57(4):357\u201366.","journal-title":"J Pineal Res"},{"key":"3125_CR18","doi-asserted-by":"publisher","DOI":"10.1155\/2014\/703175","volume":"2014","author":"F Simko","year":"2014","unstructured":"Simko F, Pechanova O, Repova Bednarova K, Krajcirovicova K, Celec P, Kamodyova N, et al. Hypertension and cardiovascular remodelling in rats exposed to continuous light: protection by ACE-inhibition and melatonin. Mediat Inflamm. 2014;2014:703175.","journal-title":"Mediat Inflamm"},{"key":"3125_CR19","doi-asserted-by":"crossref","unstructured":"Zhai M, Liu Z, Zhang B, Jing L, Li B, Li K, et al. Melatonin protects against the pathological cardiac hypertrophy induced by transverse aortic constriction through activating PGC-1beta: in vivo and in vitro studies. J Pineal Res. 2017;63(3):e12433.","DOI":"10.1111\/jpi.12433"},{"issue":"4","key":"3125_CR20","doi-asserted-by":"publisher","first-page":"258","DOI":"10.1093\/ehjcvp\/pvv037","volume":"2","author":"H Lionel","year":"2016","unstructured":"Lionel H, Opie SL. Melatonin has multiorgan effects. Eur Heart J Cardiovasc Pharmacother. 2016;2(4):258\u201365.","journal-title":"Eur Heart J Cardiovasc Pharmacother"},{"key":"3125_CR21","doi-asserted-by":"publisher","first-page":"528","DOI":"10.3389\/fphys.2018.00528","volume":"9","author":"Z Jiki","year":"2018","unstructured":"Jiki Z, Lecour S, Nduhirabandi F. Cardiovascular benefits of dietary melatonin: a myth or a reality? Front Physiol. 2018;9:528.","journal-title":"Front Physiol"},{"issue":"3","key":"3125_CR22","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1385\/ENDO:22:3:245","volume":"22","author":"L Girotti","year":"2003","unstructured":"Girotti L, Lago M, Ianovsky O, Elizari MV, Dini A, Perez Lloret S, et al. Low urinary 6-sulfatoxymelatonin levels in patients with severe congestive heart failure. Endocrine. 2003;22(3):245\u20138.","journal-title":"Endocrine."},{"issue":"3","key":"3125_CR23","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1111\/jpi.12067","volume":"55","author":"MW Hung","year":"2013","unstructured":"Hung MW, Kravtsov GM, Lau CF, Poon AM, Tipoe GL, Fung ML. Melatonin ameliorates endothelial dysfunction, vascular inflammation, and systemic hypertension in rats with chronic intermittent hypoxia. J Pineal Res. 2013;55(3):247\u201356.","journal-title":"J Pineal Res"},{"issue":"3","key":"3125_CR24","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1111\/jpi.12263","volume":"59","author":"G Maarman","year":"2015","unstructured":"Maarman G, Blackhurst D, Thienemann F, Blauwet L, Butrous G, Davies N, et al. Melatonin as a preventive and curative therapy against pulmonary hypertension. J Pineal Res. 2015;59(3):343\u201353.","journal-title":"J Pineal Res"},{"issue":"1","key":"3125_CR25","first-page":"S13","volume":"17","author":"MSD Mohammad Garakyaraghi","year":"2012","unstructured":"Mohammad Garakyaraghi MSD, Alizadeh MK. Effects of melatonin on left ventricular ejection fraction and functional class of patients with heart failure: a randomized, double-blind, placebo- controlled trial. J Res Med Sci. 2012;17(1):S13\u2013S6.","journal-title":"J Res Med Sci"},{"issue":"7","key":"3125_CR26","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3390\/molecules23071819","volume":"23","author":"F Nduhirabandi","year":"2018","unstructured":"Nduhirabandi F, Maarman GJ. Melatonin in heart failure: a promising therapeutic strategy? Molecules. 2018;23(7):1\u201318.","journal-title":"Molecules."},{"key":"3125_CR27","doi-asserted-by":"crossref","unstructured":"Chitimus DM, Popescu MR, Voiculescu SE, Panaitescu AM, Pavel B, Zagrean L, et al. Melatonin's impact on Antioxidative and anti-inflammatory reprogramming in homeostasis and disease. Biomolecules. 2020;10(9):1\u201328.","DOI":"10.3390\/biom10091211"},{"key":"3125_CR28","volume-title":"Duncan and Prasses\u2019s veterinary laboratory medicine clinical pathology","author":"S Kenneth","year":"2003","unstructured":"Kenneth S, Edward A, Keith W. Duncan and Prasses\u2019s veterinary laboratory medicine clinical pathology. 4th ed. USA: Iowa State Press; 2003.","edition":"4"},{"issue":"6","key":"3125_CR29","doi-asserted-by":"publisher","first-page":"1765","DOI":"10.1111\/jvim.14586","volume":"30","author":"A Boswood","year":"2016","unstructured":"Boswood A, Haggstrom J, Gordon SG, Wess G, Stepien RL, Oyama MA, et al. Effect of Pimobendan in dogs with preclinical Myxomatous mitral valve disease and cardiomegaly: the EPIC study-a randomized clinical trial. J Vet Intern Med. 2016;30(6):1765\u201379.","journal-title":"J Vet Intern Med"},{"issue":"3","key":"3125_CR30","doi-asserted-by":"publisher","first-page":"1127","DOI":"10.1111\/jvim.15488","volume":"33","author":"BW Keene","year":"2019","unstructured":"Keene BW, Atkins CE, Bonagura JD, Fox PR, Haggstrom J, Fuentes VL, et al. ACVIM consensus guidelines for the diagnosis and treatment of myxomatous mitral valve disease in dogs. J Vet Intern Med. 2019;33(3):1127\u201340.","journal-title":"J Vet Intern Med"},{"issue":"3","key":"3125_CR31","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1111\/j.1939-1676.2004.tb02551.x","volume":"18","author":"CC Cornell","year":"2004","unstructured":"Cornell CC, Kittleson MD, Della Torre P, Haggstrom J, Lombard CW, Pedersen HD, et al. Allometric scaling of M-mode cardiac measurements in normal adult dogs. J Vet Intern Med. 2004;18(3):311\u201321.","journal-title":"J Vet Intern Med"},{"key":"3125_CR32","volume-title":"Plumb\u2019s veterinary drug handbook","author":"DC Plumb","year":"2011","unstructured":"Plumb DC. Plumb\u2019s veterinary drug handbook. 7th ed. Stockholm, Wisconsin: PharmaVet Inc.; 2011.","edition":"7"},{"issue":"8","key":"3125_CR33","doi-asserted-by":"crossref","first-page":"1111","DOI":"10.2460\/javma.1999.215.08.1111","volume":"215","author":"PF Ashley","year":"1999","unstructured":"Ashley PF, Frank LA, Schmeitzel LP, Bailey EM, Oliver JW. Effect of oral melatonin administration on sex hormone, prolactin, and thyroid hormone concentrations in adult dogs. J Am Vet Med Assoc. 1999;215(8):1111\u20135.","journal-title":"J Am Vet Med Assoc"},{"issue":"4","key":"3125_CR34","doi-asserted-by":"publisher","first-page":"252","DOI":"10.1111\/j.1365-3164.2006.00520.x","volume":"17","author":"LA Frank","year":"2006","unstructured":"Frank LA, Donnell RL, Kania SA. Oestrogen receptor evaluation in Pomeranian dogs with hair cycle arrest (alopecia X) on melatonin supplementation. Vet Dermatol. 2006;17(4):252\u20138.","journal-title":"Vet Dermatol"},{"issue":"3","key":"3125_CR35","doi-asserted-by":"publisher","first-page":"278","DOI":"10.1111\/jvp.12749","volume":"42","author":"AC Peace","year":"2019","unstructured":"Peace AC, Kumar S, Wills R, Mackin A, Hoh CM, Archer T. Pharmacodynamic evaluation of the effects of oral melatonin on expression of the T-cell cytokines interleukin-2 and interferon gamma in the dog. J Vet Pharmacol Ther. 2019;42(3):278\u201384.","journal-title":"J Vet Pharmacol Ther"},{"issue":"4","key":"3125_CR36","doi-asserted-by":"publisher","first-page":"388","DOI":"10.1161\/CIRCULATIONAHA.113.001878","volume":"128","author":"JS Burchfield","year":"2013","unstructured":"Burchfield JS, Xie M, Hill JA. Pathological ventricular remodeling: mechanisms: part 1 of 2. Circulation. 2013;128(4):388\u2013400.","journal-title":"Circulation."},{"issue":"1","key":"3125_CR37","first-page":"62","volume":"106","author":"PS Azevedo","year":"2016","unstructured":"Azevedo PS, Polegato BF, Minicucci MF, Paiva SA, Zornoff LA. Cardiac remodeling: concepts, clinical impact, pathophysiological mechanisms and pharmacologic treatment. Arq Bras Cardiol. 2016;106(1):62\u20139.","journal-title":"Arq Bras Cardiol"},{"key":"3125_CR38","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1007\/978-1-4614-5203-4_9","volume-title":"Bohuslav Ostadal NSD, editor. Cardiac Adaptations. 4","author":"V Melenovsky","year":"2013","unstructured":"Melenovsky V. Cardiac Adaptation to Volume Overload. In: Bohuslav Ostadal NSD, editor. Cardiac Adaptations. 4. New York: springer; 2013. p. 167\u201399."},{"issue":"4","key":"3125_CR39","doi-asserted-by":"publisher","first-page":"731","DOI":"10.14202\/vetworld.2020.731-738","volume":"13","author":"YA Vatnikov","year":"2019","unstructured":"Vatnikov YA, Rudenko AA, Usha BV, Kulikov EV, Notina EA, Bykova IA, et al. Left ventricular myocardial remodeling in dogs with mitral valve endocardiosis. Vet World. 2019;13(4):731\u20138.","journal-title":"Vet World"},{"issue":"3","key":"3125_CR40","doi-asserted-by":"publisher","first-page":"362","DOI":"10.1161\/01.CIR.0000021430.04195.51","volume":"106","author":"R Nakamura","year":"2002","unstructured":"Nakamura R, Egashira K, Machida Y, Hayashidani S, Takeya M, Utsumi H, et al. Probucol attenuates left ventricular dysfunction and remodeling in tachycardia-induced heart failure: roles of oxidative stress and inflammation. Circulation. 2002;106(3):362\u20137.","journal-title":"Circulation."},{"issue":"2","key":"3125_CR41","doi-asserted-by":"publisher","first-page":"198","DOI":"10.1016\/j.bbrc.2009.02.007","volume":"381","author":"Y Li","year":"2009","unstructured":"Li Y, Sheng L, Li W, Liu W, Gong Y, Xue H, et al. Probucol attenuates atrial structural remodeling in prolonged pacing-induced atrial fibrillation in dogs. Biochem Biophys Res Commun. 2009;381(2):198\u2013203.","journal-title":"Biochem Biophys Res Commun"},{"issue":"1","key":"3125_CR42","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1186\/s12872-017-0498-1","volume":"17","author":"Q Feng","year":"2017","unstructured":"Feng Q, Lu C, Wang L, Song L, Li C, Uppada RC. Effects of renal denervation on cardiac oxidative stress and local activity of the sympathetic nervous system and renin-angiotensin system in acute myocardial infracted dogs. BMC Cardiovasc Disord. 2017;17(1):65.","journal-title":"BMC Cardiovasc Disord"},{"issue":"1","key":"3125_CR43","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1530\/JOE-16-0232","volume":"231","author":"W Pongkan","year":"2016","unstructured":"Pongkan W, Pintana H, Jaiwongkam T, Kredphoo S, Sivasinprasasn S, Chattipakorn SC, et al. Vildagliptin reduces cardiac ischemic-reperfusion injury in obese orchiectomized rats. J Endocrinol. 2016;231(1):81\u201395.","journal-title":"J Endocrinol"},{"key":"3125_CR44","doi-asserted-by":"publisher","first-page":"8416763","DOI":"10.1155\/2017\/8416763","volume":"2017","author":"G Pizzino","year":"2017","unstructured":"Pizzino G, Irrera N, Cucinotta M, Pallio G, Mannino F, Arcoraci V, et al. Oxidative stress: harms and benefits for human health. Oxidative Med Cell Longev. 2017;2017:8416763.","journal-title":"Oxidative Med Cell Longev"},{"issue":"3","key":"3125_CR45","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1111\/j.1600-079X.2010.00835.x","volume":"50","author":"M Kozirog","year":"2011","unstructured":"Kozirog M, Poliwczak AR, Duchnowicz P, Koter-Michalak M, Sikora J, Broncel M. Melatonin treatment improves blood pressure, lipid profile, and parameters of oxidative stress in patients with metabolic syndrome. J Pineal Res. 2011;50(3):261\u20136.","journal-title":"J Pineal Res"},{"issue":"12","key":"3125_CR46","doi-asserted-by":"publisher","first-page":"5347","DOI":"10.1210\/en.2003-0693","volume":"144","author":"B Prunet-Marcassus","year":"2003","unstructured":"Prunet-Marcassus B, Desbazeille M, Bros A, Louche K, Delagrange P, Renard P, et al. Melatonin reduces body weight gain in Sprague Dawley rats with diet-induced obesity. Endocrinology. 2003;144(12):5347\u201352.","journal-title":"Endocrinology."},{"key":"3125_CR47","doi-asserted-by":"crossref","unstructured":"Tung YT, Chiang PC, Chen YL, Chien YW. Effects of melatonin on lipid metabolism and circulating Irisin in Sprague-Dawley rats with diet-induced obesity. Molecules. 2020;25(15):1\u201312.","DOI":"10.3390\/molecules25153329"},{"key":"3125_CR48","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1016\/j.redox.2018.07.007","volume":"18","author":"Y Liu","year":"2018","unstructured":"Liu Y, Li LN, Guo S, Zhao XY, Liu YZ, Liang C, et al. Melatonin improves cardiac function in a mouse model of heart failure with preserved ejection fraction. Redox Biol. 2018;18:211\u201321.","journal-title":"Redox Biol"},{"issue":"4","key":"3125_CR49","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1007\/BF01252131","volume":"49","author":"J Saaf","year":"1980","unstructured":"Saaf J, Wetterberg L, Backstrom M, Sundwall A. Melatonin administration to dogs. J Neural Transm. 1980;49(4):281\u20135.","journal-title":"J Neural Transm"},{"key":"3125_CR50","doi-asserted-by":"crossref","unstructured":"Zhou H, Zhang Y, Hu S, Shi C, Zhu P, Ma Q, et al. Melatonin protects cardiac microvasculature against ischemia\/reperfusion injury via suppression of mitochondrial fission-VDAC1-HK2-mPTP-mitophagy axis. J Pineal Res. 2017;63(1):1\u201314.","DOI":"10.1111\/jpi.12413"},{"key":"3125_CR51","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1016\/j.lfs.2018.11.055","volume":"217","author":"WX Zhang","year":"2019","unstructured":"Zhang WX, He BM, Wu Y, Qiao JF, Peng ZY. Melatonin protects against sepsis-induced cardiac dysfunction by regulating apoptosis and autophagy via activation of SIRT1 in mice. Life Sci. 2019;217:8\u201315.","journal-title":"Life Sci"},{"issue":"1","key":"3125_CR52","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1111\/jpi.12033","volume":"55","author":"H Zhang","year":"2013","unstructured":"Zhang H, Liu D, Wang X, Chen X, Long Y, Chai W, et al. Melatonin improved rat cardiac mitochondria and survival rate in septic heart injury. J Pineal Res. 2013;55(1):1\u20136.","journal-title":"J Pineal Res"},{"key":"3125_CR53","doi-asserted-by":"publisher","first-page":"41337","DOI":"10.1038\/srep41337","volume":"7","author":"L Yu","year":"2017","unstructured":"Yu L, Gong B, Duan W, Fan C, Zhang J, Li Z, et al. Melatonin ameliorates myocardial ischemia\/reperfusion injury in type 1 diabetic rats by preserving mitochondrial function: role of AMPK-PGC-1alpha-SIRT3 signaling. Sci Rep. 2017;7:41337.","journal-title":"Sci Rep"},{"key":"3125_CR54","doi-asserted-by":"crossref","unstructured":"Odinokova I, Baburina Y, Kruglov A, Fadeeva I, Zvyagina A, Sotnikova L, et al. Effect of melatonin on rat heart mitochondria in acute heart failure in aged rats. Int J Mol Sci. 2018;19(6):1\u201316.","DOI":"10.3390\/ijms19061555"},{"issue":"2","key":"3125_CR55","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1111\/jvim.14647","volume":"31","author":"MJ Reimann","year":"2017","unstructured":"Reimann MJ, Haggstrom J, Moller JE, Lykkesfeldt J, Falk T, Olsen LH. Markers of oxidative stress in dogs with Myxomatous mitral valve disease are influenced by sex, neuter status, and serum cholesterol concentration. J Vet Intern Med. 2017;31(2):295\u2013302.","journal-title":"J Vet Intern Med"},{"issue":"4","key":"3125_CR56","doi-asserted-by":"publisher","first-page":"537","DOI":"10.1111\/j.1939-1676.2005.tb02724.x","volume":"19","author":"LM Freeman","year":"2005","unstructured":"Freeman LM, Rush JE, Milbury PE, Blumberg JB. Antioxidant status and biomarkers of oxidative stress in dogs with congestive heart failure. J Vet Intern Med. 2005;19(4):537\u201341.","journal-title":"J Vet Intern Med"},{"issue":"10-11","key":"3125_CR57","doi-asserted-by":"publisher","first-page":"943","DOI":"10.1016\/j.clinbiochem.2009.04.012","volume":"42","author":"MC Chen","year":"2009","unstructured":"Chen MC, Chang JP, Liu WH, Yang CH, Chen CJ, Fang CY, et al. Increased serum oxidative stress in patients with severe mitral regurgitation: a new finding and potential mechanism for atrial enlargement. Clin Biochem. 2009;42(10-11):943\u20138.","journal-title":"Clin Biochem"},{"issue":"5","key":"3125_CR58","doi-asserted-by":"publisher","first-page":"1520","DOI":"10.1111\/jvim.12425","volume":"28","author":"MJ Reimann","year":"2014","unstructured":"Reimann MJ, Haggstrom J, Mortensen A, Lykkesfeldt J, Moller JE, Falk T, et al. Biopterin status in dogs with myxomatous mitral valve disease is associated with disease severity and cardiovascular risk factors. J Vet Intern Med. 2014;28(5):1520\u20136.","journal-title":"J Vet Intern Med"},{"issue":"10","key":"3125_CR59","doi-asserted-by":"publisher","first-page":"2954","DOI":"10.18632\/aging.101602","volume":"10","author":"J Fang","year":"2018","unstructured":"Fang J, Yan Y, Teng X, Wen X, Li N, Peng S, et al. Melatonin prevents senescence of canine adipose-derived mesenchymal stem cells through activating NRF2 and inhibiting ER stress. Aging (Albany NY). 2018;10(10):2954\u201372.","journal-title":"Aging (Albany NY)"},{"issue":"5","key":"3125_CR60","doi-asserted-by":"publisher","first-page":"3142","DOI":"10.1002\/ehf2.12829","volume":"7","author":"M Sadeghi","year":"2020","unstructured":"Sadeghi M, Khosrawi S, Heshmat-Ghahdarijani K, Gheisari Y, Roohafza H, Mansoorian M, et al. Effect of melatonin on heart failure: design for a double-blinded randomized clinical trial. ESC Heart Fail. 2020;7(5):3142\u201350.","journal-title":"ESC Heart Fail"},{"issue":"4","key":"3125_CR61","doi-asserted-by":"publisher","first-page":"1129","DOI":"10.18388\/abp.2003_3637","volume":"50","author":"RJ Reiter","year":"2003","unstructured":"Reiter RJ, Tan DX, Mayo JC, Sainz RM, Leon J, Czarnocki Z. Melatonin as an antioxidant: biochemical mechanisms and pathophysiological implications in humans. Acta Biochim Pol. 2003;50(4):1129\u201346.","journal-title":"Acta Biochim Pol"},{"key":"3125_CR62","doi-asserted-by":"crossref","unstructured":"Mahsa; Rastegar; Moghaddam; Mansouri SA, Mohammad; Khazaie. Melatonin and Exercise: Their Effects on Malondialdehyde and Lipid Peroxidation. In: Dragoi CM, editor. Melatonin Biology, Clinical and Pharmaceutical Approaches: IntechOpen Limited; 2018. p. 105-20.","DOI":"10.5772\/intechopen.79561"},{"issue":"4","key":"3125_CR63","doi-asserted-by":"publisher","first-page":"285","DOI":"10.5326\/0460285","volume":"46","author":"K Baldwin","year":"2010","unstructured":"Baldwin K, Bartges J, Buffington T, Freeman LM, Grabow M, Legred J, et al. AAHA nutritional assessment guidelines for dogs and cats. J Am Anim Hosp Assoc. 2010;46(4):285\u201396.","journal-title":"J Am Anim Hosp Assoc"},{"issue":"6","key":"3125_CR64","doi-asserted-by":"publisher","first-page":"1803","DOI":"10.1111\/jvim.15331","volume":"32","author":"MJ Acierno","year":"2018","unstructured":"Acierno MJ, Brown S, Coleman AE, Jepson RE, Papich M, Stepien RL, et al. ACVIM consensus statement: guidelines for the identification, evaluation, and management of systemic hypertension in dogs and cats. J Vet Intern Med. 2018;32(6):1803\u201322.","journal-title":"J Vet Intern Med"},{"issue":"3","key":"3125_CR65","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1530\/JOE-16-0002","volume":"229","author":"W Pongkan","year":"2016","unstructured":"Pongkan W, Pintana H, Sivasinprasasn S, Jaiwongkam T, Chattipakorn SC, Chattipakorn N. Testosterone deprivation accelerates cardiac dysfunction in obese male rats. J Endocrinol. 2016;229(3):209\u201320.","journal-title":"J Endocrinol"},{"issue":"1","key":"3125_CR66","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1016\/j.jchromb.2005.06.035","volume":"827","author":"R Mateos","year":"2005","unstructured":"Mateos R, Lecumberri E, Ramos S, Goya L, Bravo L. Determination of malondialdehyde (MDA) by high-performance liquid chromatography in serum and liver as a biomarker for oxidative stress. Application to a rat model for hypercholesterolemia and evaluation of the effect of diets rich in phenolic antioxidants from fruits. J Chromatogr B Analyt Technol Biomed Life Sci. 2005;827(1):76\u201382.","journal-title":"J Chromatogr B Analyt Technol Biomed Life Sci"},{"issue":"4","key":"3125_CR67","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1111\/j.1939-1676.1993.tb01015.x","volume":"7","author":"WP Thomas","year":"1993","unstructured":"Thomas WP, Gaber CE, Jacobs GJ, Kaplan PM, Lombard CW, Moise NS, et al. Recommendations for standards in transthoracic two-dimensional echocardiography in the dog and cat. Echocardiography Committee of the Specialty of cardiology, American College of Veterinary Internal Medicine. J Vet Intern Med. 1993;7(4):247\u201352.","journal-title":"J Vet Intern Med"}],"container-title":["BMC Veterinary Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12917-021-03125-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12917-021-03125-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12917-021-03125-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,9,15]],"date-time":"2024-09-15T21:35:51Z","timestamp":1726436151000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcvetres.biomedcentral.com\/articles\/10.1186\/s12917-021-03125-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,1,7]]},"references-count":67,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2022,12]]}},"alternative-id":["3125"],"URL":"https:\/\/doi.org\/10.1186\/s12917-021-03125-z","relation":{},"ISSN":["1746-6148"],"issn-type":[{"value":"1746-6148","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,1,7]]},"assertion":[{"value":"30 June 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 December 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 January 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was approved by the Faculty of Veterinary Medicine Chiang Mai University Animal Care and Use Committee (FVM \u2013 ACUC) (approved ethical number: S17\/2562) and written informed consent was obtained before the dogs were included in the study. All methods are reported in accordance with ARRIVE guidelines () for the reporting of animal experiments.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no conflicts of interest. This clinical trial was conducted in the absence of any commercial or financial relationship that could be construed as a potential conflict of interest.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"24"}}